[A case of advanced breast cancer successfully treated with combined tamoxifen and epitiostanol]. 1988

Y Konishi, and T Morimoto, and K Komaki, and T Yamakawa, and N Mituyama, and T Tanaka, and Y Oomine, and Y Monden
2nd Dept. of Surgery, School of Medicine, University of Tokushima.

A patient with stage IV advanced breast cancer with multiple metastasis (bones of the whole body, lungs) were treated by ovariectomy, administration of an non-steroidal antiestrogen (tamoxifen) and mild chemotherapeutic drugs, with favorable results. After four years, however, the patient had a relapse of the cancer. A steroidal antiestrogen (epitiostanol) was then administered with satisfactory results. When a breast cancer relapse occurs in patients once treated successfully with endocrinotherapy, a different form of endocrinotherapy should be tried. There is a possibility that the mechanism of action of Epitiostanol, which is regarded as a steroidal antiestrogen, is different from that of tamoxifen in which an estrogen receptor (ER) system is included.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D010052 Ovariectomy The surgical removal of one or both ovaries. Castration, Female,Oophorectomy,Bilateral Ovariectomy,Bilateral Ovariectomies,Castrations, Female,Female Castration,Female Castrations,Oophorectomies,Ovariectomies,Ovariectomies, Bilateral,Ovariectomy, Bilateral
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004965 Estrogen Antagonists Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. Estradiol Antagonists,Antagonists, Estradiol,Antagonists, Estrogen
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Y Konishi, and T Morimoto, and K Komaki, and T Yamakawa, and N Mituyama, and T Tanaka, and Y Oomine, and Y Monden
November 1992, Gan to kagaku ryoho. Cancer & chemotherapy,
Y Konishi, and T Morimoto, and K Komaki, and T Yamakawa, and N Mituyama, and T Tanaka, and Y Oomine, and Y Monden
January 1995, Nihon geka hokan. Archiv fur japanische Chirurgie,
Y Konishi, and T Morimoto, and K Komaki, and T Yamakawa, and N Mituyama, and T Tanaka, and Y Oomine, and Y Monden
August 1992, Gan to kagaku ryoho. Cancer & chemotherapy,
Y Konishi, and T Morimoto, and K Komaki, and T Yamakawa, and N Mituyama, and T Tanaka, and Y Oomine, and Y Monden
January 2020, Case reports in oncology,
Y Konishi, and T Morimoto, and K Komaki, and T Yamakawa, and N Mituyama, and T Tanaka, and Y Oomine, and Y Monden
April 1999, Breast cancer (Tokyo, Japan),
Y Konishi, and T Morimoto, and K Komaki, and T Yamakawa, and N Mituyama, and T Tanaka, and Y Oomine, and Y Monden
December 2019, Gan to kagaku ryoho. Cancer & chemotherapy,
Y Konishi, and T Morimoto, and K Komaki, and T Yamakawa, and N Mituyama, and T Tanaka, and Y Oomine, and Y Monden
November 2013, Gan to kagaku ryoho. Cancer & chemotherapy,
Y Konishi, and T Morimoto, and K Komaki, and T Yamakawa, and N Mituyama, and T Tanaka, and Y Oomine, and Y Monden
November 2008, Gan to kagaku ryoho. Cancer & chemotherapy,
Y Konishi, and T Morimoto, and K Komaki, and T Yamakawa, and N Mituyama, and T Tanaka, and Y Oomine, and Y Monden
December 2020, Gan to kagaku ryoho. Cancer & chemotherapy,
Y Konishi, and T Morimoto, and K Komaki, and T Yamakawa, and N Mituyama, and T Tanaka, and Y Oomine, and Y Monden
August 1993, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!